A new BMJ Medicine cohort study suggests that hormone replacement therapy (HRT) prescribing in UK primary care varies by ethnicity, deprivation, and region. The finding matters because it points to a familiar problem in general practice and women’s health: access to menopause care is not always experienced equally. For clinicians, commissioners, and practice teams, this is useful appraisal material. It shifts the conversation away from whether HRT matters and toward a harder question: who is able to access evidence-based menopause care consistently, and who is not?

Key Takeaway

The study suggests that patterns of HRT prescribing are not evenly distributed across the UK primary care population. Differences linked to ethnicity, deprivation, and geography raise concern that menopause care may still be shaped by structural inequality as much as by clinical need.

Why This Matters for UK General Practice

• Menopause care is now a major primary care workload area, with growing public awareness and patient expectation.
• Variation in HRT prescribing may reflect barriers in access, consultation quality, continuity, clinician confidence, or service design.
• If prescribing patterns differ systematically by deprivation or ethnicity, practices may need to look beyond individual consultations and examine population-level equity.

Questions for Reflection

• Are menopause consultations equally accessible across different patient groups in primary care?
• Could continuity, appointment access, or local prescribing culture be influencing who receives HRT?
• What would an equity-focused review of menopause care look like in a GP practice or PCN?

Bottom Line

This BMJ Medicine paper is a reminder that good menopause care is not only about having effective treatments. It is also about making sure access to those treatments is fair, timely, and consistent across the population. Source: BMJ Medicine – view the original article.